Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
#Contraceptive Devices Market Revenue Outlook: What CAGR Lies Ahead Through 2030?#_x000D_
The contraceptive devices market size has shown robust expansion in recent years. Its value is anticipated to rise from $13.55 billion in 2025 to $14.4 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. This growth during the historical period can be attributed to several factors including heightened awareness of family planning methods, governmental support for population control programs, a rise in the incidence of unintended pregnancies, the broadening of reproductive health services, and the increasing accessibility of over-the-counter contraceptive products._x000D_
_x000D_
The contraceptive devices market size is anticipated to experience substantial expansion over the coming years. This market is projected to reach $18.31 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. Factors contributing to this growth during the forecast period include a heightened emphasis on reproductive autonomy and women’s well-being, an increased need for long-lasting and easy-to-manage contraceptive methods, the proliferation of digital health services and online pharmacy platforms, the growing acceptance of male contraception options, and the rise in sexual health programs initiated by public bodies and NGOs. Key trends foreseen for this period encompass a surge in the use of long-acting reversible contraceptives, a greater call for contraceptive choices managed by females, a widening acceptance of non-hormonal contraceptive devices, broadened availability of contraception via online and public avenues, and an intensified focus on offering dual protection against both pregnancy and STIs._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Contraceptive Devices Market Development Factors: What’s Supporting Demand?#_x000D_
The rising incidence of sexually transmitted diseases is anticipated to propel the expansion of the contraceptive device market in the future. Sexually transmitted diseases (STDs) are infections primarily transmitted via sexual contact, affecting various parts of the body and potentially leading to a range of symptoms and health complications. The increase in sexually transmitted diseases stems from factors like elevated sexual activity, insufficient protection, inadequate sexual health education, and challenges in accessing healthcare and testing. Contraceptive devices, especially condoms, are vital for sexually transmitted diseases because they establish a barrier that minimizes the risk of transmission by preventing direct contact with infectious fluids and lesions. For instance, in July 2024, a report from the UK Health Security Agency, a UK-based government agency, revealed that England registered 401,800 new STI diagnoses in 2023, indicating a 4.7% increase from the 383,789 cases reported in 2022. Diagnoses for gonorrhea climbed by 7.5%, from 79,268 in 2022 to 85,223 in 2023. Meanwhile, infectious syphilis diagnoses saw a 9.4% rise, increasing from 8,693 in 2022 to 9,513 in 2023. Therefore, the growing prevalence of sexually transmitted diseases is driving the growth of the contraceptive device market._x000D_
_x000D_
#Contraceptive Devices Market Segments: Where Is Growth Concentrated?#_x000D_
The contraceptive devices market covered in this report is segmented – _x000D_
_x000D_
1) By Product Type: Male Contraceptive Devices, Female Contraceptive Devices, Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices, Sub-Dermal Implants, Others Product Types_x000D_
2) By Technology: Hormonal Contraceptives, Barrier Contraceptives_x000D_
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channel And Non-Governmental Organization (NGO), Other Distribution Channels_x000D_
_x000D_
Subsegments:_x000D_
1) By Male Contraceptive Devices: Male Condoms, Vasectomy Devices, Male Contraceptive Injections, Male Contraceptive Pills _x000D_
2) By Female Contraceptive Devices: Female Condoms, Diaphragms And Sponges, Vaginal Rings, Intrauterine Devices (IUDs), Sub-Dermal Implants, Emergency Contraceptive Devices _x000D_
3) By Female Condoms: Internal Latex Female Condoms, Non-Latex Female Condoms _x000D_
4) By Diaphragms And Sponges: Silicone Diaphragms, Latex Diaphragms, Contraceptive Sponges _x000D_
5) By Vaginal Rings: NuvaRing (And Other Hormonal Vaginal Rings), Non-Hormonal Vaginal Rings _x000D_
6) By Intrauterine Devices (IUDs): Copper IUDs, Hormonal IUDs, Non-Hormonal IUDs _x000D_
7) By Sub-Dermal Implants: Hormonal Implants, Non-Hormonal Implants_x000D_
8) By Other Product Types: Contraceptive Patches, Contraceptive Injections, Contraceptive Pills, Contraceptive Gel And Creams_x000D_
_x000D_
#Contraceptive Devices Market Transformation Trends: What Innovations Are Driving Change?#_x000D_
Major companies operating in the contraceptive device market are innovating products like contraceptive vaginal rings to offer a convenient, low-maintenance birth control method requiring a single monthly insertion. A contraceptive vaginal ring is a flexible, hormone-releasing device inserted into the vagina, which prevents pregnancy by continuously emitting hormones to inhibit ovulation and thicken cervical mucus. For example, in October 2023, Xiromed LLC, a US-based pharmaceuticals company, launched the EnilloRing. Developed by Xiromed, the EnilloRing is a contraceptive vaginal ring combining etonogestrel and ethinyl estradiol. It is designed for extended use, staying in place for three weeks, followed by a one-week ring-free interval to effectively prevent pregnancy._x000D_
_x000D_
#Contraceptive Devices Market Industry Leaders And Competitive Landscape#_x000D_
Major companies operating in the contraceptive devices market are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Organon Group, Hologic Inc., CooperSurgical Inc., Cipla Inc., Mankind Pharma Ltd., TTK HealthCare Ltd., Merck Sharp & Dohme Corp., Evofem Biosciences Inc., Veru Inc., Agile Therapeutics Inc., Janssen Global Services LLC, HLL Lifecare Ltd., Mayer Laboratories Inc., V-Care Pharma Pvt. Ltd., Vardhaman Lifecare Pvt. Ltd., Actavis Pharma LLC, Pregna International Limited _x000D_
_x000D_
#View The Full Contraceptive Devices Market Report:#_x000D_
_x000D_
#Contraceptive Devices Market Regional Analysis And Leading Geography#_x000D_
North America was the largest region in the contraceptive devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.